Evidence map›Paper›PMID 24686137›Full record

ArticleMolecular psychiatry2014

Response to Selveraj et al.

S V Faraone, T J Spencer, B K Madras, Y Zhang-James, J Biederman

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

S V FaraoneDepartments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
T J SpencerPediatric Psychopharmacology Unit, Psychiatry Service, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
B K Madras1] New England Primate Research Center, Division of Neuroscience, Southborough, MA, USA [2] Harvard Medical School, Boston, MA, USA.
Y Zhang-JamesDepartments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
J BiedermanPediatric Psychopharmacology Unit, Psychiatry Service, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Funding

New England Primate Research Center Base GrantP51OD011103 · OD · HARVARD MEDICAL SCHOOL · PI FLIER, JEFFREY S · 2012 to 2013
$24.7M
EVALUATION OF NOVEL COCAINE MEDICATIONSR01DA011558 · NIDA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MADRAS, BERTHA K · 1997 to 2005
$2.2M
MOLECULAR PROBES FOR SPECIFIC COCAINE RECOGNITION SITESR37DA006303 · NIDA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MADRAS, BERTHA K · 1998 to 2005
$2.0M
Cocaine-Molecular Targets/Brain Imaging and MedicationsK05DA015305 · NIDA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MADRAS, BERTHA K · 2002 to 2009
$581k
NIDA NIH HHS K05 DA015305NIDA NIH HHS R01 DA011558NIDA NIH HHS R37 DA006303NIH HHS P51 OD011103
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dopamine Plasma Membrane Transport ProteinsHumansDopamine Plasma Membrane Transport Proteins

Identifiers

PMID24686137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.